3-((R)-1-hydroxy-2-((1S,4aS,8aS)-5,5,8a-trimethyl-2-methylenedecahydronaphthalen-1-yl)ethyl)furan-2(5H)-one

Catalog No. :
ACROMQ282
CAS No. :
958885-86-4
Molecular Formula :
C20H30O3
Molecular Weight :
318.46

IUPAC Name:3-((R)-1-hydroxy-2-((1S,4aS,8aS)-5,5,8a-trimethyl-2-methylenedecahydronaphthalen-1-yl)ethyl)furan-2(5H)-one

3-((R)-1-hydroxy-2-((1S,4aS,8aS)-5,5,8a-trimethyl-2-methylenedecahydronaphthalen-1-yl)ethyl)furan-2(5H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-((R)-1-hydroxy-2-((1S,4aS,8aS)-5,5,8a-trimethyl-2-methylenedecahydronaphthalen-1-yl)ethyl)furan-2(5H)-one
IUPAC Name3-((R)-1-hydroxy-2-((1S,4aS,8aS)-5,5,8a-trimethyl-2-methylenedecahydronaphthalen-1-yl)ethyl)furan-2(5H)-one
MDL No.MFCD20260777
Molecular FormulaC20H30O3
Molecular Weight318.46
SMILESC=C1CC[C@H]2C(C)(C)CCC[C@]2(C)[C@H]1C[C@@H](O)C1=CCOC1=O
InChI KeyNNNUJNWMFLYQTF-PFRQMTDMSA-N
Synonym12-Hydroxy-8(17),13-labdadien-16,15-olide;12-HYDROXY-8(17),13-LABDADIEN-16;Epivitexolide D;(12R)-hydroxylabda-8(17),13-dien-15(16)-olide;2(5H)-Furanone, 3-[(1R)-2-[(1S,4aS,8aS)-decahydro-5,5,8a-trimethyl-2-methylene-1-naphthalenyl]-1-hydroxyethyl]-;VitexolideE/12-Hydroxy-8(17)13-labdadien-1615-olide;Vitexolide E
CAS No.958885-86-4

Synthetic Route by SureRoute

1. ACROMQ282 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACROMQ282 route product structure diagram
    ACROMQ282958885-86-4
Inquiry

2. ACROMQ282 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACROMQ282 route product structure diagram
    ACROMQ282958885-86-4
Inquiry

Comments (0)